The weekly litigation news digest is live. Subscribe now

IP Verse

Pegylated Liposomes For Delivery Of Immunogen-Encoding Rna

Patent No. EP4066856 (titled "Pegylated Liposomes For Delivery Of Immunogen-Encoding Rna") was filed by Glaxosmithkline on Aug 31, 2011. The application was issued on Dec 7, 2022.

Patent Summary

UPC Cases New

Latest UPC cases involving this patent.

Case NumberFiling DatePlaintiffProceeding Type
UPC_CFI_619/2025Jul 4, 2025GlaxosmithklineInfringement
UPC_CFI_621/2025Jul 3, 2025GlaxosmithklineInfringement

Patent Family

Patent Family

Patent Oppositions (4)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
JG OPPOSITIONSSep 7, 2023MEWBURN ELLIS
WEICKMANN & WEICKMANNSep 7, 2023-
SANOFISep 6, 2023ELKINGTON AND FIFE
THOMANNSep 6, 2023THOMANN

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP4066856

GLAXOSMITHKLINE
Application Number
EP22174931A
Filing Date
Aug 31, 2011
Status
Granted And Under Opposition
Nov 4, 2022
Publication Date
Dec 7, 2022
External Links
Slate, EP4066856B1, Google Patents